IBREXAFUNGERP vs ICATIBANT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IBREXAFUNGERP vs ICATIBANT: Safety Overview
| Metric | IBREXAFUNGERP | ICATIBANT |
|---|---|---|
| Total FAERS Reports | 129 | 5,363 |
| Deaths Reported | 6 | 234 |
| Death Rate | 4.7% | 4.4% |
| Hospitalizations | 9 | 2,451 |
| Average Patient Age | 44.4 yrs | 46.3 yrs |
| % Female Patients | 85.2% | 75.0% |
| FDA Approval Date | Jun 1, 2021 | Aug 14, 2023 |
| Manufacturer | N/A | Alembic Pharmaceuticals Inc. |
| Route | N/A | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |